Results
183
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
183 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$31.58 | 0.9% | 96.5% | US$5.2b | US$29.42 | PS27x | E60.9% | n/a | Semiconductors | ||
EH | US$14.39 | 6.0% | -7.8% | US$910.7m | US$24.98 | PS42.2x | E74.3% | n/a | Capital Goods | ||
ATAT | US$18.82 | 4.4% | 9.0% | US$2.6b | US$27.17 | PE19.3x | E22.1% | 0.8% | Consumer Services | ||
GCT | US$31.89 | 4.8% | 347.3% | US$1.3b | US$52.33 | PE12.4x | E21.3% | n/a | Retail | ||
TBBB | US$23.35 | -2.6% | n/a | US$2.6b | US$26.84 | PS1x | E94.7% | n/a | Consumer Retailing | ||
PDD | US$137.34 | 4.1% | 102.9% | US$190.7b | US$205.59 | PE17.4x | E23.2% | n/a | Retail | ||
CG | US$40.59 | 1.8% | 30.1% | US$14.6b | US$48.45 | PS6.6x | E23.6% | 3.4% | Diversified Financials | ||
SMCI | US$847.00 | -4.9% | 238.1% | US$49.6b | US$1,032.47 | PE47.3x | E40.2% | n/a | Tech | ||
BRDG | US$7.64 | 5.4% | -35.2% | US$924.3m | US$9.88 | PB3.6x | E98.2% | 8.6% | Diversified Financials | ||
DUOL | US$193.82 | -7.1% | 45.1% | US$8.4b | US$252.23 | PE183.3x | E48.1% | n/a | Consumer Services | ||
MAX | US$12.52 | -4.1% | 31.9% | US$824.4m | US$25.33 | PS1.6x | E88.1% | n/a | Media | ||
ZKH | US$3.85 | -2.8% | n/a | US$620.1m | US$15.74 | PB1.4x | E104.4% | n/a | Capital Goods | ||
CBNK | US$20.18 | 0.2% | 12.4% | US$280.5m | US$26.10 | PB1.1x | E27.2% | 1.6% | Banks | ||
RYAN | US$57.46 | -1.7% | 29.4% | US$15.0b | US$58.08 | PE107.5x | E56.6% | 0.8% | Insurance | ||
HSAI | US$4.55 | 7.3% | -57.4% | US$580.0m | US$10.07 | PS2.3x | E71.0% | n/a | Automobiles | ||
EVOK | US$0.54 | 6.7% | -67.4% | US$4.6m | US$7.00 | PB1.3x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
ESTA | US$43.73 | -0.3% | -31.6% | US$1.2b | US$65.14 | PS7.7x | E68.2% | n/a | Healthcare | ||
HSCS | US$4.75 | -10.4% | -94.8% | US$3.1m | US$67.50 | PS167.4x | E66.8% | n/a | Healthcare | ||
MDGL | US$271.67 | -4.9% | 23.2% | US$5.8b | US$365.07 | PB6.8x | E63.8% | n/a | Pharmaceuticals & Biotech | ||
CARG | US$24.33 | -6.0% | 12.3% | US$2.5b | US$26.85 | PE69.9x | E30.0% | n/a | Media | ||
HNVR | US$16.20 | -1.8% | -8.5% | US$117.4m | US$18.50 | PB0.6x | E20.9% | 2.5% | Banks | ||
HOFV | US$2.77 | -7.7% | -68.4% | US$18.1m | US$8.00 | PB0.2x | E71.1% | n/a | Consumer Services | ||
SMWB | US$7.41 | -2.9% | 20.1% | US$595.1m | US$10.40 | PS2.7x | E107.1% | n/a | Software | ||
SPRY | US$9.09 | 6.8% | 48.3% | US$880.8m | US$19.00 | PS88077.8x | E58.7% | n/a | Pharmaceuticals & Biotech |